Correlation Between Mink Therapeutics and Theriva Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Theriva Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Theriva Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Theriva Biologics, you can compare the effects of market volatilities on Mink Therapeutics and Theriva Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Theriva Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Theriva Biologics.

Diversification Opportunities for Mink Therapeutics and Theriva Biologics

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Mink and Theriva is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Theriva Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theriva Biologics and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Theriva Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theriva Biologics has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Theriva Biologics go up and down completely randomly.

Pair Corralation between Mink Therapeutics and Theriva Biologics

Given the investment horizon of 90 days Mink Therapeutics is expected to generate 0.82 times more return on investment than Theriva Biologics. However, Mink Therapeutics is 1.22 times less risky than Theriva Biologics. It trades about -0.01 of its potential returns per unit of risk. Theriva Biologics is currently generating about -0.03 per unit of risk. If you would invest  251.00  in Mink Therapeutics on August 30, 2024 and sell it today you would lose (179.00) from holding Mink Therapeutics or give up 71.31% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Mink Therapeutics  vs.  Theriva Biologics

 Performance 
       Timeline  
Mink Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's forward-looking signals remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Theriva Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Theriva Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Mink Therapeutics and Theriva Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mink Therapeutics and Theriva Biologics

The main advantage of trading using opposite Mink Therapeutics and Theriva Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Theriva Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theriva Biologics will offset losses from the drop in Theriva Biologics' long position.
The idea behind Mink Therapeutics and Theriva Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Transaction History
View history of all your transactions and understand their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities